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tion of superoxide (Maridonneau-Parini et al. 1989; Perretti et al. 1995 Perretti et al. , 1996b . Because of these properties of annexin I and because BK-induced PE is dependent on both polymorphonu-
clear leukocytes and prostaglandins, we tested the hypothesis that the effect of corticosterone to inhibit SPGN-dependent Activation of primary afferent nociceptors induces a neural BK-induced PE is mediated via stimulation of the production endocrine-mediated inhibition of the inflammatory response and release of annexin I. via a circuit that includes ascending spinal pathways and activation of the hypothalamic-pituitary-adrenal (HPA) axis (Green et al. 1995) . During chronic inflammation, produced by injec-M E T H O D S tion of complete Freund's adjuvant in the rat hind paw, or Animals
The costs of publication of this article were defrayed in part by the
The experiments were performed on 300-to 400-g male payment of page charges. The article must therefore be hereby marked Sprague-Dawley rats (Bantin and Kingman, Fremont, CA). The ''advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
rats were housed two to a cage in a temperature (72 { 2ЊC) and humidity (45 { 5%) controlled environment and were maintained shown to exacerbate the inflammatory response when administered subcutaneously before the injection of zymosan to induce inflamon a 12-h light/dark cycle (lights on at 06:00). Food and water were available ad libitum. To minimize stress, animals were only mation (Perretti et al. 1996a ). This antibody has been shown to have no cross-reactivity with other members of the annexin family handled during cage cleaning (bi-weekly), and one investigator administered the pentobarbital sodium anesthesia. Experiments (Perretti et al. 1996a ). We co-perfused LCPS1, or normal sheep serum, with BK through the knee joint, immediately after saline were performed between 0900 and 1500 h. All procedures involving animals in our experimental protocols have been reviewed and baseline samples, to immunoneutralize endogenous annexin. To verify that the anti-annexin I antibody could immunoneutralize the approved by the Committee on Animal Research at the University of California, San Francisco.
effect of annexin I in this system, 25 min after beginning BK / anti-annexin I antibody perfusion, annexin I (100 ng/ml) was added to the perfusion fluid, in one knee joint, as described above.
PE
Rats were anesthetized with pentobarbital sodium (Anthony Products, Arcadia, CA; 65 mg/kg). Skin overlying both knees was Anti-annexin antibody administration interaction with excised to expose the joint capsules, and rats were then given an corticosterone-or noxious electrical stimulation-induced intravenous injection of Evans blue dye (50 mg/kg, in a volume inhibition of BK-induced PE of 2.5 ml/kg). A 30-gauge hypodermic needle was then inserted for the inflow of perfusion fluid (250 ml/min; controlled by a Anti-annexin antibody (1:60 dilution) (M. Perretti, personal syringe pump, Sage Instruments model 341B); after perfusion of communication) was administered with BK after the baseline per-100-200 ml of fluid, a second needle (25 gauge) was inserted into fusion period (i.e., 15 min after the start of the perfusion period). the joint cavity for outflow of the perfusion fluid (250 ml/min; Corticosterone infusion (5 mg/min iv) or noxious electrical stimusyringe pump, Sage Instruments model 351). Both knees were lation was initiated 40 min after the start of the perfusion period perfused; samples of perfusion fluid were collected over 5-min and continued for the remainder of the experiment. intervals for a period of 70 min, and samples were analyzed for Evans blue dye concentration by spectrophotometric measurement of absorbance at 620 nm, which is linearly related to dye concentra-Corticosterone assay tion (Carr and Wilhelm 1964) . After establishment of baseline levels of PE in the first three samples, BK (150 nM) was added Blood samples (50-100 ml) were collected from pentobarbitalto the perfusing fluid and remained present in the fluid for the anesthetized animals by venipuncture (tail vein) immediately beduration of the experiment. Other drugs added to the perfusion fore and during noxious (25 mA) and nonnoxious (2.5 mA) electrifluid, as indicated in individual experiments, remained in the perfu-cal stimulation. Samples were immediately centrifuged and plasma sion fluid for the duration of the experiment.
taken and stored at 020ЊC until assayed. Total plasma corticosterone was assayed with a double antibody 125 I radio-immunoassay
Noxious electrical stimulation
kit (ICN Biomedicals, Costa Mesa, CA) as previously described (Akana et al. 1985) . The assay has a sensitivity of detection of Two stainless steel electrodes (23-gauge hypodermic needles) 0.5 mg/ml and has a cross-reactivity reported by ICN Biomedicals were placed transversely through the plantar side of one hind paw as 0.34% for desoxycorticosterone and 0.1% for testosterone. (Ç10 mm apart); the stimulus intensity necessary to excite C fibers has been previously determined electrophysiologically (Green et al. 1995) . Noxious (C-fiber strength) electrical stimulation was Materials applied to the hind paw during the assessment of BK-induced PE starting 25 min after the initiation of BK perfusion in the knee Evans blue dye, BK triacetate, corticosterone (11b,21-dihyroxyjoint, rats received noxious electrical stimulation (25 mA, 0.25 ms 4-pregnene-3,20-dione), PAF (l-a-phosphatidylcholine, b-acetylduration pulses, 3 Hz) via the two stimulating electrodes, which t-o-alkyl), normal sheep serum, and dimethyl sulfoxide were obcontinued for the duration of the experiment.
tained from Sigma Chemical Company (St. Louis, MO). Annexin was obtained from Zymed Laboratories (South San Francisco,
Corticosterone administration
CA). Anti-annexin I antibody (LCPS1) was a generous gift of Dr. M. Perretti (The William Harvey Research Institute, St. BartholoCorticosterone was administered intra-articularly (ia) or intravemew's Hospital, London, UK). Corticosterone was dissolved in nously (iv). When administered intra-articularly, corticosterone ethanol and diluted in 0.2% bovine serum albumin (in 0.9% saline) was co-perfused with BK at either 1-or 10-mM concentrations.
to give a final concentration of 2% ethanol. Infusion of the vehicle When administered intravenously, corticosterone was administered did not affect BK-induced PE (Green et al. 1997) ; all other drugs via a 25-gauge infusion catheter inserted into the lateral tail vein, were dissolved in 0.9% saline. at a rate of 1 ml/h, to deliver a dose of 0.05, 0.5, or 5 mg/min (rate controlled by a Sage 351 syringe pump).
Statistics Annexin administration
Data were analyzed using repeated measures analysis of variance To determine the effect of exogenously administered annexin I in (ANOVA) with one between subjects factor, treatment, with 2 BK-induced PE, 25 min after beginning BK perfusion, annexin I levels (e.g., control and electrical stimulation, or control and corti-(100 ng/ml) was added to the perfusion fluid, in one knee joint, and costerone), and one within subjects factor, time, with 10 levels remained in the perfusion fluid for the remainder of the experiment.
(45-90 min, 5-min intervals). We present the results of the analysis of the main effect, treatment; differences were considered sig-
Intra-articular corticosterone inhibits BK-induced PE only at a dose that inhibits BK-induced PE in the contralateral knee
A two-way repeated ANOVA showed a significant inhibitory effect of intra-articular corticosterone on BK-induced PE [F(3,19) Å 16.075, P õ 0.05]. Post hoc Fisher comparisons revealed that BK-induced PE was not significantly attenuated by intra-articular corticosterone at 1 mM, but intraarticular perfusion of corticosterone 10 mM through one knee joint did significantly attenuate BK-induced PE (P õ 0.05, Fig. 3 ). However, in the contralateral knee, which was only perfused with BK, the magnitude of PE was also decreased (BK vs. BK / corticosterone 10 mM ia contralateral, P õ 0.05), and this inhibition was not significantly different from that seen in the ipsilateral knee (BK / corticosterone 10 mM ia contralateral vs. BK / corticosterone 10 mM ia ipsilateral, P ú 0.05). At lower intra-articular concentrations, corticosterone (i.e.,°1 mM ia) did not inhibit BK-induced PE either ipsi-or contralateral to the corticosterone perfused knee (data not shown). These data suggest that corticosterone does not act in the knee joint to inhibit BK-induced PE. Subsequent experiments were designed to test the hypothesis that corticosterone exerts its inhibitory effect on . Once a drug is added to the perfusate, it continues to be present for the duration of the experiment. Inset: plasma corticosterone levels were determined 10 min before onset of electrical stimulation and at several time points thereafter. Noxious electrical (q, n Å 7) stimulation significantly increases plasma corticosterone compared with unstimulated control (q, n Å 8).
R E S U L T S

Electrical stimulation and systemic (intravenous) corticosterone inhibit BK-induced PE
Continuous perfusion of BK ( 150 nM ) through the knee joint produced a sustained increase in PE for the duration of the 90-min perfusion period ( Fig. 1 ) . Noxious electrical stimulation inhibited BK-induced PE in both knee joints [ BK vs. BK / electrical stimulation, F ( 1,11 ) Å 10.543; P õ 0.05 ] . Plasma corticosterone concentrations were significantly [ F ( 1,16 ) Å 8.517, P õ 0.05 ] increased after noxious electrical stimulation ( which activates both A and C fibers ) compared with nonstimulated controls ( Fig. 1, inset ) . A two-way repeated ANOVA showed a significant inhibitory effect of intravenous corticosterone on BK-induced PE [ F ( 3,31 ) Å 5.77, P õ 0.05 ] . Post hoc Fisher comparisons revealed that BK-induced PE was The magnitude of inhibition produced by either noxious the perfusion fluid. In 3 other groups of rats, corticosterone was infused electrical stimulation or intravenous corticosterone on intravenously, starting 40 min after the onset of the perfusion of BK, at a BK-induced PE was the same in both knee joints ( data rate of 0.05 mg/min (q, n Å 5), 0.5 mg/min (ᮀ, n Å 12), or 5 mg/min (, Neither intravenous corticosterone nor intra-articular annexin inhibits platelet activating factor (PAF) -induced PE in the rat knee joint. FIG . 3. Intra-articular corticosterone inhibits BK-induced PE both ipsiand contralateral to corticosterone in the rat knee joint. After establishment After establishment of baseline PE in the 1st 3 samples, PAF (35 nM; ᭺, n Å 8) was added to the perfusion fluid and, for the remainder of the of baseline PE in the 1st 3 samples, BK (150 nM; ᭺, n Å 8) was added to the perfusion fluid and, for the remainder of the experiment, was the experiment, was the only substance in the perfusion fluid. In a 2nd group of rats (q, n Å 7) corticosterone (5 mg/min) was infused intravenously, only substance in the perfusion fluid. In a 2nd group of rats ( q, n Å 7), corticosterone (1 mM) was co-perfused with BK intra-articularly. In a 3rd starting 40 min after the onset of the perfusion of PAF, while in a 3rd group of rats (ᮀ, n Å 9) annexin I (100 ng/ml) was co-perfused with PAF group of rats (ᮀ, n Å 6), corticosterone (10 mM) was co-perfused through one knee joint, while the contralateral knee joint (, n Å 6) was perfused through the knee joint. with BK alone.
Annexin I perfusion does not inhibit PAF-induced PE in that knee joint [BK vs. BK / annexin I ipsilateral,
Similar to the effect of intravenous corticosterone admin-F(1,11) Å 8.986 P õ 0.05; Fig. 4 ], but not in the contralatistration on PAF-induced PE (Green et al. 1997) , intraeral knee, which only received BK (BK vs. BK / annexin articular co-perfusion of PAF with annexin I (100 ng/ml) I contralateral, P ú 0.05). Annexin I inhibition was not did not inhibit the magnitude of PAF-induced PE (PAF vs. statistically different (P ú 0.05) from that produced by PAF / annexin I, P ú 0.05; Fig. 5 ). either corticosterone (iv) or electrical stimulation.
Anti-annexin antibody antagonizes inhibition of BKinduced PE by annexin I, electrical stimulation or corticosterone (iv)
Inhibition of BK-induced PE by noxious electrical stimulation was blocked by perfusion of anti-annexin I antibody (LCPS1, 1:60 dilution) through the knee joint [BK / electrical stimulation / LCPS1 vs. BK / electrical stimulation vs. BK / control sheep serum F(2,17) Å 5.801P õ 0.05, with Fishers post hoc analysis revealing significant effect of LCPS1; Fig. 6A ]. LCPS1 completely blocked the inhibition of BK-induced PE produced by corticosterone administration [5 mg/min iv; BK / LCPS1 vs. BK / corticosterone (iv) / LCPS1 vs. BK / corticosterone (iv), F(2,19) Å 6.801P õ 0.05, with Fishers post hoc analysis revealing significant effect of LCPS1; Fig. 6B ]. In control experiments, to demonstrate the ability of anti-annexin I antibodies to block effects of annexin I in the knee joint of the rat, immunoneutralization of annexin I with LCPS1 completely blocked the inhibitory effect of annexin I on BK- induced  FIG . 4 . Intra-articular annexin inhibits BK-induced PE in the rat knee PE (BK vs. BK / annexin I / anti-annexin I antibody, joint, similar to the inhibition produced by noxious electrical stimulation P ú 0.05; Fig. 6B ). Perfusion of normal sheep serum (1:60 or intravenous corticosterone. After establishment of baseline PE in the 1st dilution) had no effect on BK-induced PE or its inhibition 3 samples, BK (150 nM; ᭺, n Å 8) was added to the perfusion fluid and, by noxious electrical stimulation.
for the remainder of the experiment, was the only substance in the perfusion fluid. In a 2nd group of rats ( , n Å 6), annexin I (100 ng/ml) was coperfused through one knee joint, while the contralateral knee joint (ᮀ, n Å D I S C U S S I O N 6) was perfused with BK alone. Inhibition of BK-induced PE produced by
In this study, we have shown that in the knee joint of intravenous corticosterone (᭡, n Å 6) or noxious electrical stimulation (᭝, n Å 6) are shown for comparison. 6. Anti-annexin antibody attenuates inhibition of BK-induced PE produced by either electrical stimulation or by corticosterone (iv). A: after establishment of baseline PE in the 1st 3 samples, BK (150 nM) and normal sheep serum (1:60 dilution; ᭺, n Å 8) were added to the perfusion fluid and, for the remainder of the experiment, were the only substances in the perfusion fluid. In a 2nd group of rats ( ᮀ, n Å 6), C fibers were stimulated electrically (25 mA, 3 Hz), via electrodes in one hind paw, starting 40 min after the onset of the perfusion of BK, while in a 3rd group ( q, n Å 7) noxious electrical stimulation was started 40 min after the onset of anti-annexin I antibody (1:60 dilution) co-perfused with BK through the knee joint. B: after establishment of baseline PE in the 1st 3 samples, BK (150 nM; ᭺, n Å 8) was added to the perfusion fluid and, for the remainder of the experiment, was the only substance in the perfusion fluid. The inhibition of BK-induced PE produced by corticosterone (5 mg/min iv; q, n Å 12) is attenuated when co-perfused with anti-annexin I antibody ( ᮀ, n Å 6). Similarly, inhibition of BK-induced PE produced by annexin I (100 ng/ml ia; , n Å 6) is also attenuated when co-perfused with anti-annexin I antibody (᭝, n Å 6). stimulation, which is HPA axis dependent (Green et al. acin inhibits BK-induced PE , and migration of leukocytes is necessary for the production of PE by 1997) and increases plasma corticosterone levels, or by intravenous corticosterone infusion cannot be explained by a BK (Bjerknes et al. 1991; Green et al. 1993 ). Polymorphonuclear leukocytes have binding sites for annexin I, but they local action of corticosterone in the knee joint. Corticosterone infused locally into the knee joint affected BK-induced also release annexin I on exposure to glucocorticoids . Annexin I inhibits f MLP-induced PE only at concentrations high enough to have a systemic action (i.e., the contralateral knee joint was also inhibited), polymorphonuclear leukocyte adhesion to endothelial monolayers (Perretti et al. 1995) and causes adherent polymorphosimilar to that seen with intravenously administered corticosterone. However, we have found that local perfusion of nuclear leukocytes to detach and return to the circulation (Mancuso et al. 1995) . Furthermore, for those polymorphoannexin I through the knee joint mimics, and anti-annexin I antibody antagonizes, the inhibition of BK-induced PE nuclear leukocytes that stay attached and enter diapedesis, there is a three-to fourfold increased latency to transmigraproduced by both noxious electrical stimulation and intravenous corticosterone. Thus we have provided evidence that tion (Mancuso et al. 1995) . Thus annexin I potently inhibits a number of different leukocyte mechanisms, which result the inhibitory effect of corticosterone on BK-induced PE in the knee joint as well as inhibition of BK-induced PE pro-in an annexin I-mediated decrease in polymorphonuclear leukocyte numbers at sites of inflammation (Perretti et al. duced by C-fiber activity is mediated by annexin I.
Annexin I is widely distributed in mammalian tissues; in 1993). Thus annexin I would be expected to affect BKinduced PE, which is polymorphonuclear leukocyte depenparticular it is produced in cell types associated with the inflammatory response [e.g., leukocytes and synoviocytes in dent, but not PAF-induced PE, which is polymorphonuclear leukocyte independent ; PAF-induced inflamed joints (Goulding et al. 1995) ]. Annexin I inhibits cytosolic phospholipase A 2 activity ; PE is not inhibited by intravenous corticosterone (Green et al. 1995) or by annexin I. Kim et al. 1994) and production of arachidonic acid metabolites [e.g., prostaglandin E 2 and leukotriene B 4 (Errasfa and Taken together, our data suggest that after activation of the feedback inhibitory pathway by either an inflammatory Russo 1989)] and other pro-inflammatory mediators, such as tumor necrosis factor a, from mononuclear cells (Sudlow process or activation of nociceptors (Green et al. 1995 (Green et al. , 1997 , the increased level of circulating corticosterone acts et al. 1996) . Annexin I also inhibits recruitment of polymorphonuclear leukocytes to sites of inflammation (Errasfa and on polymorphonuclear leukocytes to release annexin I. Release of annexin I from polymorphonuclear leukocytes is a Russo 1989), transendothelial passage of polymorphonuclear leukocytes (Perretti et al. 1996b) , and stimulated de-very rapid (õ15 min) process (Comera and Russo Marie 1995) , which correlates well with the observed time course granulation of primary granules (Perretti et al. 1995) . Of note, inhibition of arachidonic acid synthesis with indometh-of inhibition of BK-induced PE after activation of the feed-
11-23-98 14:20:08 neupa LP-Neurophys back pathway. We would then expect that released annexin I et al. 1998) synthesis and release, and inhibition of either inhibits BK-but not PAF-induced PE . inhibits the transmigration of polymorphonuclear leukocytes In addition to releasing annexin, glucocorticoids stimulate into the knee joint synovium, by causing the polymorphonuthe production and/or release of other mediators e.g., soclear leukocytes to detach from the synovial endothelium matostatin and angiotensin converting enzyme, which may and return to the circulation (Mancuso et al. 1995) . Further influence the magnitude of the inflammatory response. For support for this hypothesis comes from our recent observaexample, somatostatin synthesis is stimulated by glucocortition that noxious electrical stimulation attenuates BK-stimucoids and somatostatin analogues potently inhibit the inlated accumulation of polymorphonuclear leukocytes into flammatory response, through actions on leukocytes and cythe microcirculation of the synovium (E. Lo, P. G. Green, tokines (Karalis et al. 1995 ). Angiotensin converting en-H. J. Strausbaugh, and J. D. Levine, unpublished observazyme has been shown to be markedly up-regulated by tions).
corticosterone; this enzyme cleaves BK (with a K m lower Our data suggest that, at least with respect to the control than for cleavage of angiotensin I), and this results in a of BK-induced PE over the period studied (õ90 min), gludecrease of BK levels at sites of inflammation following cocorticoid exerts its anti-inflammatory effect by a systemic glucocorticoid administration. However, although corticoaction (possibly on circulating polymorphonuclear leukosterone has several potential modes of action to inhibit the cytes), and not by a local action in the knee joint synovium.
inflammatory response, our observation that feedback inhibiThis is consistent with the observation that locally (intradertion of the inflammatory response can be attenuated with mal) administered glucocorticoids have no effect on polyimmunoneutralizing doses of anti-annexin I antibody sugmorphonuclear leukocyte accumulation while systemically gests that action by annexin I accounts for much of the administered glucocortoids inhibit polymorphonuclear leuinhibitory effect of noxious stimulus-induced inhibition of kocyte accumulation (Yarwood et al. 1993 ). Interestingly, BK-induced PE. It should be noted, however, that there is glucocorticoids given intra-articularly over weeks have been likely to be an annexin I-independent component of noxious shown to reduce arthritic severity (suppression of inflammastimulation of the hind paw, because we have recently shown tion and pannus measured using magnetic resonance imthat noxious stimulation (produced by capsaicin injected inaging) (Huppertz et al. 1995) , and although glucocorticoids tradermally) is partially mediated by the sympathoadrenal may have anti-inflammatory effects at sites of administra-pathway (Miao et al. 1998) . tion, e.g., by virtue of having a direct action on endothelial In summary, we have provided evidence that the feedback cells (Cronstein et al. 1992; Yarwood et al. 1993 ) and/or inhibition produced by inflammation or by C-fiber stimulaby their ability to be vasoconstrictors (Marks and Sawyer tion results in release of corticosterone, which induces the 1986), our data suggest that a primary anti-inflammatory synthesis and/or release of annexin I, possibly from circulateffect of local corticosteroid injection may occur only after ing cells, which then acts to inhibit BK-induced PE. systemic absorption. Importantly, Perretti and Flower (1993) observed that although both systemic and local ad- suggests that to have an annexin I-mediated action, glucocorticoids must act on leukocytes before they migrate into Received 30 April 1998; accepted in final form 14 September 1998. tissues.
Annexin I could affect PE by a mechanism that is indepen-
